Chair’s welcome and introduction
Multiple Myeloma in Taiwan: Where Are We Now and Where Are We Going With the Care of MM Patients?
- Continuous therapy in multiple myeloma: A critical review and current perspectives
- Proteasome inhibition in multiple myeloma therapy: Current evidence and future research
Real-world effectiveness of Ninlaro: local case sharing
Summary and close